Eleven years ago, when I first launched Maven, women's health felt strangely quiet
If the primary goal is fat loss and metabolic support, start your treatment now with a structured protocol that integrates GLP-1 medications, dietary coaching, and evidence-based adjunctive therapies
Diarrhoea or constipation: Changes in bowel movement are common
GLP-1 agonists are medicines that help people with type 2 diabetes and those who want to lose weight
Rifaximin was not associated with DROs overall (OR 1.07, 95% CI 0.801.43, P =0.65) or within income strata (high: 1.07, 95% CI 0.591.92, P =0.82, upper-middle: 1.18, 95% CI 0.741.85, P =0.49, low/low-middle: 1.04, 95% CI 0.601.81, P =0.90) despite sensitivity analyses
Enteric coatings could protect peptides from gastric acid but did not address enzymatic degradation or poor absorption in the small intestine